Labat Africa Ltd (JSE:LAB) — Market Cap & Net Worth
Market Cap & Net Worth: Labat Africa Ltd (LAB)
Labat Africa Ltd (JSE:LAB) has a market capitalization of $5.05 Million (ZAC9.50 Billion) as of September 21, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #28659 globally and #215 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Labat Africa Ltd's stock price ZAC3.00 by its total outstanding shares 3165108879 (3.17 Billion). Also see LAB total assets for a full breakdown of the balance sheet.
Labat Africa Ltd Market Cap History: 2015 to 2026
Labat Africa Ltd's market capitalization history from 2015 to 2026. Data shows change from $252.31 Million to $5.05 Million (-29.57% CAGR). Also see cash flow conversion of Labat Africa Ltd for how efficiently the company converts equity into cash flow.
Labat Africa Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Labat Africa Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Labat Africa Ltd (LAB) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.07x
Labat Africa Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.11x
Labat Africa Ltd's market cap is 0.11 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $47.10 Million | $14.31 Million | $8.40 Million | 3.29x | 5.61x |
| 2017 | $63.92 Million | $52.01 Million | $4.64 Million | 1.23x | 13.77x |
| 2018 | $65.60 Million | $73.35 Million | $12.58 Million | 0.89x | 5.21x |
| 2019 | $68.97 Million | $616.43 Million | -$72.94 Million | 0.11x | N/A |
| 2020 | $72.33 Million | $40.25 Million | $946.00K | 1.80x | 76.46x |
| 2021 | $48.78 Million | $29.27 Million | -$22.75 Million | 1.67x | N/A |
| 2022 | $16.82 Million | $30.72 Million | -$48.11 Million | 0.55x | N/A |
| 2023 | $11.77 Million | $49.53 Million | -$86.90 Million | 0.24x | N/A |
| 2024 | $11.77 Million | $48.54 Million | -$25.80 Million | 0.24x | N/A |
| 2025 | $13.46 Million | $199.40 Million | $117.87 Million | 0.07x | 0.11x |
Competitor Companies of LAB by Market Capitalization
Companies near Labat Africa Ltd in the global market cap rankings as of September 21, 2026. Review Labat Africa Ltd (LAB) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Labat Africa Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #612 globally with a market cap of $44.88 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #612 | GALDERMA GROUP AG | NYSE:GALDY | $44.88 Billion | $38.49 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Labat Africa Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Labat Africa Ltd's market cap moved from $252.31 Million to $ 5.05 Million, with a yearly change of -29.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ZAC5.05 Million | -62.50% |
| 2025 | ZAC13.46 Million | +14.29% |
| 2024 | ZAC11.77 Million | 0.00% |
| 2023 | ZAC11.77 Million | -30.00% |
| 2022 | ZAC16.82 Million | -65.52% |
| 2021 | ZAC48.78 Million | -32.56% |
| 2020 | ZAC72.33 Million | +4.88% |
| 2019 | ZAC68.97 Million | +5.13% |
| 2018 | ZAC65.60 Million | +2.63% |
| 2017 | ZAC63.92 Million | +35.71% |
| 2016 | ZAC47.10 Million | -81.33% |
| 2015 | ZAC252.31 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 21st, 2026 the market cap of Labat Africa Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.05 Million USD |
| MoneyControl | $5.05 Million USD |
| MarketWatch | $5.05 Million USD |
| marketcap.company | $5.05 Million USD |
| Reuters | $5.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Labat Africa Ltd
Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more